Biomarkers of chronic alcohol misuse

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
   Google Scholar
• Hasin DS, O’Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834–851.
   PubMed Web of Science ®Google Scholar
• Mathurin P, Deltenre P. Effect of binge drinking on the liver: an alarming public health issue? Gut. 2009;58(5):613–617.
   Web of Science ®Google Scholar
• Allen JP. Use of biomarkers of heavy drinking in health care practice. Mil Med. 2003;168(5):364–367.
   Web of Science ®Google Scholar
• Ethanol generation 2 Cobas (ETOH2). [package insert] Roche-Diagnostic, Mannheim, Germany. 2012. French.
   Google Scholar
• Pizon AF, Becker CE, Bikin D. The clinical significance of variations in ethanol toxicokinetics. J Med Toxicol. 2007;3(2):63–72.
   Google Scholar
• Giang Y-S, Wang S-M, Tsai C-C, Ming-Chang L, Ng C-J. Analyzing alcohol in breath, blood, saliva, and urine for forensic purposes: Taiwanese population. Forensic Sci J. 2007;6(1):1–19.
   Google Scholar
• Jones AW. Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework. Forensic Sci Int. 2010;200(1–3):1–20.
   PubMed Web of Science ®Google Scholar
• Schmitt G, Droenner P, Skopp G, Aderjan R. Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci. 1997;42(6):1099–1102.
   Web of Science ®Google Scholar
• Helander A, Böttcher M, Fehr C, Dahmen N, Beck O. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol. 2009;44(1):55–61.
   PubMed Web of Science ®Google Scholar
• Böttcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol. 2008;43(1):46–48.
   PubMed Web of Science ®Google Scholar
• Jatlow P, O’Malley SS. Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready? Alcohol Clin Exp Res. 2010;34(6):968–975.
   Web of Science ®Google Scholar
• Helander A, Péter O, Zheng Y. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol. 2012;47(5):552–557.
   Web of Science ®Google Scholar
• Zheng Y, Beck O, Helander A. Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta. 2011 15;412(15–16):1428–1435.
   Google Scholar
• Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98 Suppl 2:31–43.
   Google Scholar
• Hanigan MH, Frierson HF Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem. 1996;44(10):1101–1108.
   Web of Science ®Google Scholar
• Hanigan MH, Ricketts WA. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry. 1993;32(24):6302–6306.
   PubMed Web of Science ®Google Scholar
• Lieberman MW, Wiseman AL, Shi ZZ, et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci U S A. 1996;93(15):7923–7926.
   Web of Science ®Google Scholar
• Jean JC, Liu Y, Brown LA, Marc RE, Klings E, Joyce-Brady M. Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. Am J Physiol Lung Cell Mol Physiol. 2002;283(4):L766–L776.
   PubMed Web of Science ®Google Scholar
• Paolicchi A, Sotiropuolou M, Perego P, et al. gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. Eur J Cancer. 2003;39(7):996–1003.
   Web of Science ®Google Scholar
• Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010;13(1):36–41.
   PubMedGoogle Scholar
• Carter BZ, Wiseman AL, Orkiszewski R, Ballard KD, Ou CN, Lieberman MW. Metabolism of leukotriene C4 in gamma-glutamyl transpeptidase-deficient mice. J Biol Chem. 1997;272(19):12305–12310.
   Web of Science ®Google Scholar
• Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet. 1971;2(7720):376–377.
   Web of Science ®Google Scholar
• Barouki R, Chobert MN, Finidori J, Aggerbeck M, Nalpas B, Hanoune J. Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology. 1983;3(3):323–329.
   Web of Science ®Google Scholar
• Corti A, Franzini M, Paolicchi A, Pompella A. Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res. 2010;30(4):1169–1181.
   PubMed Web of Science ®Google Scholar
• Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem. 1969;15(2):124–136.
   PubMed Web of Science ®Google Scholar
• Schumann G, Bonora R, Ceriotti F, et al; International Federation of Clinical Chemistry and Laboratory Medicine. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. Clin Chem Lab Med. 2002;40(7):734–738.
   Web of Science ®Google Scholar
• Siekmann L, Bonora R, Burtis CA, et al; International Federation of Clinical Chemistry and Laboratory Medicine. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 7. Certification of four reference materials for the determination of enzymatic activity of gamma-glutamyltransferase, lactate dehydrogenase, alanine aminotransferase and creatine kinase accord. Clin Chem Lab Med. 2002;40(7):739–745.
   Web of Science ®Google Scholar
• Infusino I, Bonora R, Panteghini M. Traceability in clinical enzymology. Clin Biochem Rev. 2007;28(4):155–161.
   Google Scholar
• Steinmetz J, Schiele F, Gueguen R, Férard G, Henny J; Periodic Health Examination Centers Laboratory Working Group. Standardization of gamma-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits. Clin Chem Lab Med. 2007;45(10):1373–1380.
   Web of Science ®Google Scholar
• Lessinger JM, Schiele F, Vialle A, et al. [Enzyme calibrators: principle and practical use]. Ann Biol Clin (Paris). 2002;60(3):281–286. French.
   Web of Science ®Google Scholar
• Whitfield JB, Pounder RE, Neale G, Moss DW. Serum-glytamyl transpeptidase activity in liver disease. Gut. 1972;13(9):702–708.
   Web of Science ®Google Scholar
• Cabrera-Abreu JC, Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem. 2002;39(Pt 1):22–25.
   PubMed Web of Science ®Google Scholar
• Bagrel A, d’Houtaud A, Gueguen R, Siest G. Relations between reported alcohol consumption and certain biological variables in an “unselected” population. Clin Chem. 1979;25(7):1242–1246.
   Web of Science ®Google Scholar
• Sillanaukee P, Massot N, Jousilahti P, et al. Dose response of laboratory markers to alcohol consumption in a general population. Am J Epidemiol. 2000;152(8):747–751.
   PubMed Web of Science ®Google Scholar
• Salmela KS, Laitinen K, Nyström M, Salaspuro M. Carbohydrate-deficient transferrin during 3 weeks’ heavy alcohol consumption. Alcohol Clin Exp Res. 1994;18(2):228–230.
   Web of Science ®Google Scholar
• Belfrage P, Berg B, et al. Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl. 1973;552:1–44.
   PubMedGoogle Scholar
• Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med. 1997;26(3):305–310.
   Web of Science ®Google Scholar
• SAMHSA. The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision. Advisory. May 13, 2012;11(2):1–8. Available from: http://adaiclearinghouse.org/downloads/Advisory-The-Role-of-Biomarkers-in-the-Treatment-of-Alcohol-Use-Disorders-434.pdf. Accessed November 20, 2013.
   Google Scholar
• Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol. 1997;146(12):1019–1024.
   Web of Science ®Google Scholar
• Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC. Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. Dig Dis Sci. 1985; 30(3):211–214.
   PubMed Web of Science ®Google Scholar
• Majumdar SK, Dias N, Aps EJ. Relationship between hepatic histology and conventional biochemical liver function test in chronic alcoholic patients. Drug Alcohol Depend. 1991;28(2):211–214.
   Web of Science ®Google Scholar
• Monteiro MG, Masur J. Monitoring alcoholism treatment: the appropriateness of choice between gamma GT or MCV evaluation after a short time of abstinence. Alcohol. 1986;3(4):223–226.
   Web of Science ®Google Scholar
• Lamy J, Baglin MC, Ferrant JP, Weill J. [Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol]. Clin Chim Acta. 30 1974;56(2):169–173. French.
   Google Scholar
• Lamy J, Baglin MC, Aron E, Weill J. [Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol in cirrhotics (author transl)]. Clin Chim Acta. 1975;60(1):97–101. French.
   Web of Science ®Google Scholar
• Wu A, Chanarin I, Levi AJ. Macrocytosis of chronic alcoholism. Lancet. 1974;1(7862):829–831.
   Web of Science ®Google Scholar
• Buffet C, Chaput JC, Albuisson F, Subtil E, Etienne JP. [Macrocytosis in chronic alcoholic hepatitis (author’s transl)]. Arch Fr Mal App Dig. 1975;64(4):309–315. French.
   Google Scholar
• Latvala J, Parkkila S, Niemelä O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res. 2004;28(4):619–624.
   Web of Science ®Google Scholar
• Latvala J. Effect of Alcohol Consumption and Acetaldehyde on Blood Cells and Molecules [dissertation]. Tampere, Finland: University of Tampere; 2004.
   Google Scholar
• Lindenbaum J. Hematologic complications of alcohol abuse. Semin Liver Dis. 1987;7(3):169–181.
   Web of Science ®Google Scholar
• Niemelä O, Parkkila S. Alcoholic macrocytosis – is there a role for acetaldehyde and adducts? Addict Biol. 2004;9(1):3–10.
   Web of Science ®Google Scholar
• Hietala J, Koivisto H, Latvala J, Anttila P, Niemelä O. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res. 2006;30(10):1693–1698.
   Web of Science ®Google Scholar
• Kaartinen K, Niemelä O, Syrjänen J, et al. IgA immune responses against acetaldehyde adducts and biomarkers of alcohol consumption in patients with IgA glomerulonephritis. Alcohol Clin Exp Res. 2009;33(7):1231–1237.
   Web of Science ®Google Scholar
• Koivisto H, Hietala J, Anttila P, Parkkila S, Niemelä O. Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications. J Lab Clin Med. 2006;147(4):191–196.
   Web of Science ®Google Scholar
• Hasselblatt M, Martin F, Maul O, Ehrenreich H, Kernbach-Wighton G. Persistent macrocytosis following abstinence from chronic alcohol use. JAMA. 2001;286(23):2946.
   Web of Science ®Google Scholar
• Cohen JA, Kaplan MM. The SGOT/SGPT ratio – an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24(11):835–838.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Gordon RE, Bradbury M, Stump D, Kiang CL, Berk PD. Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology. 1998;27(4):1064–1074.
   Web of Science ®Google Scholar
• Matloff DS, Selinger MJ, Kaplan MM. Hepatic transaminase activity in alcoholic liver disease. Gastroenterology. 1980;78(6):1389–1392.
   PubMed Web of Science ®Google Scholar
• Nalpas B, Vassault A, Le Guillou A, et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology. 1984;4(5):893–896.
   Web of Science ®Google Scholar
• Salaspuro M. Characteristics of laboratory markers in alcohol-related organ damage. Scand J Gastroenterol. 1989;24(7):769–780.
   PubMed Web of Science ®Google Scholar
• Flahaut C, Michalski JC, Danel T, Humbert MH, Klein A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology. 2003;13(3):191–198.
   Web of Science ®Google Scholar
• Landberg E, Åström E, Kågedal B, Påhlsson P. Disialo-trisialo bridging of transferrin is due to increased branching and fucosylation of the carbohydrate moiety. Clin Chim Acta. 2012;414:58–64.
   Web of Science ®Google Scholar
• Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem. 2001;47(1):13–27.
   PubMed Web of Science ®Google Scholar
• Stibler H, Allgulander C, Borg S, Kjellin KG. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand. 1978;204(1–2):49–56.
   Google Scholar
• Stibler H, Borg S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand J Clin Lab Invest. 1991;51(1):43–51.
   PubMed Web of Science ®Google Scholar
• Sillanaukee P, Pönniö M, Seppä K. Sialic acid: new potential marker of alcohol abuse. Alcohol Clin Exp Res. 1999;23(6):1039–1043.
   PubMed Web of Science ®Google Scholar
• Sillanaukee P, Strid N, Allen JP, Litten RZ. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcohol Clin Exp Res. 2001;25(1):34–40.
   Web of Science ®Google Scholar
• Helander A, Eriksson G, Stibler H, Jeppsson JO. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem. 2004;7(7):1225–1233.
   Google Scholar
• Jeppsson JO, Arndt T, Schellenberg F, et al; International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Standardization of Carbohydrate-deficient Transferin (IFCC-WG-CDT). Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med. 2007;45(4):558–562.
   Web of Science ®Google Scholar
• Dibbelt L. Does trisialo-transferrin provide valuable information for the laboratory diagnosis of chronically increased alcohol consumption by determination of carbohydrate-deficient transferrin? Clin Chem. 2000;46(8 Pt 1):1203–1205.
   Web of Science ®Google Scholar
• Gonzalo P, Pecquet M, Bon C, et al. Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods. Clin Chim Acta. 2012;413(7–8):712–718.
   Web of Science ®Google Scholar
• Potter BJ, Chapman RW, Nunes RM, Sorrentino D, Sherlock S. Transferrin metabolism in alcoholic liver disease. Hepatology. 1985;5(5):714–721.
   Web of Science ®Google Scholar
• Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin Exp Res. 1986;10(5):535–544.
   Web of Science ®Google Scholar
• Lesch OM, Walter H, Antal J, et al. Alcohol dependence: is carbohydrate-deficient transferrin a marker for alcohol intake? Alcohol Alcohol. 1996;31(3):257–264.
   Web of Science ®Google Scholar
• Walter H, Hertling I, Benda N, et al. Sensitivity and specificity of carbohydrate-deficient transferrin in drinking experiments and different patients. Alcohol. 2001;25(3):189–194.
   Web of Science ®Google Scholar
• Lesch OM, Walter H, Antal J, et al. Carbohydrate-deficient transferrin as a marker of alcohol intake: a study with healthy subjects. Alcohol Alcohol. 1996;31(3):265–271.
   Web of Science ®Google Scholar
• Appenzeller BM, Schneider S, Maul A, Wennig R. Relationship between blood alcohol concentration and carbohydrate-deficient transferrin among drivers. Drug Alcohol Depend. 2005;79(2):261–265.
   PubMed Web of Science ®Google Scholar
• Stibler H, Borg S. Carbohydrate composition of serum transferrin in alcoholic patients. Alcohol Clin Exp Res. 1986;10(1):61–64.
   Web of Science ®Google Scholar
• Weykamp C, Wielders JP, Helander A, et al; IFCC Working Group on Standardization of Carbohydrate-Deficient Transferrin (WG-CDT). Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med. 2013;51(5):991–996.
   Web of Science ®Google Scholar
• Capillarys CDT. [technical notice]. SEBIA, Evry, France. 2008. French.
   Google Scholar
• N Latex CDT Kit. [technical notice]. Siemens Healthcare Diagnostic Products GmbH, Marbury, Germany. 2009. French.
   Google Scholar